HEALTH — Nightingale Health Oyj Cashflow Statement
0.000.00%
Last trade - 00:00- €106.64m
- €37.59m
- €4.18m
- 58
- 13
- 94
- 56
Annual cashflow statement for Nightingale Health Oyj, fiscal year end - June 30th, EUR millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.02 | -3.73 | -9.72 | -16.1 | -18.1 |
| Depreciation | |||||
| Non-Cash Items | 0.309 | 0.451 | 4.23 | 6.01 | 3.28 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.605 | -0.115 | 1.17 | -1.63 | 0.784 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.09 | -3.17 | -1.87 | -7.47 | -7.33 |
| Capital Expenditures | -3.04 | -8.19 | -0.895 | -1.37 | -0.833 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.384 | -5.71 | -6.95 | -3.58 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.04 | -7.8 | -6.61 | -8.32 | -4.41 |
| Financing Cash Flow Items | — | — | 122 | 0.288 | 0.185 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.395 | 5.4 | 121 | -2.86 | -2.58 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.53 | -5.57 | 113 | -18.5 | -14.6 |